Safety and efficacy of trifluridine/tipiracil plus bevacizumab in RAS mutated patients with metastatic colorectal cancer

被引：0
|
作者：
Michalaki, Vasiliki
Theodosopoulos, Thedosios
Vezakis, Antonios
Papaconstantinou, Ioannis
Kontis, Ioannis
Dafnios, Nikolaos
Frangoulidis, George
Karandrea, Despina
Papadimitriou, Christos
机构：
[1] Natl & Kapodistrian Univ Athens, Aretaieion Hosp, Sch Med, Dept Surg 2, Athens, Greece
[2] Aretaieion Hosp, Dept Surg 2, Athens, Greece
[3] Natl & Kapodistrian Univ, Aretaieion Hosp, Dept Surg 2, Athens, Greece
[4] Univ Athens, Aretaieion Hosp, Dept Surg 2, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Aretaieion Hosp, Oncol, Dept Surg 2, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15605
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Daisuke Kotani
    Yasutoshi Kuboki
    Satoshi Horasawa
    Asumi Kaneko
    Yoshiaki Nakamura
    Akihito Kawazoe
    Hideaki Bando
    Hiroya Taniguchi
    Kohei Shitara
    Takashi Kojima
    Akihito Tsuji
    Takayuki Yoshino
    BMC Cancer, 19
  • [22] The safety and efficacy of trifluridine-tipiracil for metastatic colorectal cancer: A pharmacy perspective
    Chan, Betty M.
    Hochster, Howard S.
    Lenz, Heinz-Josef
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (06) : 339 - 348
  • [23] RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Grell, Peter
    Batko, Stanislav
    Pirsthuk, Alina
    Borilova, Simona
    Polachova, Katerina
    Mazuchova, Blanka
    Tomasek, Jiri
    Fabian, Pavel
    Berkovcova, Jitka
    Bardelcik, Miroslav
    Obermannova, Radka
    Buchler, Tomas
    Kiss, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL)
  • [24] Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer
    Zaniboni, Alberto
    Barone, Carlo Antonio
    Banzi, Maria Chiara
    Bergamo, Francesca
    Blasi, Livio
    Bordonaro, Roberto
    Di Bartolomeo, Maria
    Di Costanzo, Francesco
    Frassineti, Giovanni Luca
    Garufi, Carlo
    Giuliani, Francesco
    Latiano, Tiziana Pia
    Martinelli, Erika
    Personeni, Nicola
    Racca, Patrizia
    Tamburini, Emiliano
    Tonini, Giuseppe
    Besse, Marie Georges
    Spione, Mario
    Falcone, Alfredo
    FUTURE ONCOLOGY, 2021, 17 (18) : 2315 - 2324
  • [25] Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
    Ozet, Ahmet
    Dane, Faysal
    Aykan, Nuri Faruk
    Yalcin, Suayib
    Evrensel, Turkkan
    Ozkan, Metin
    Karabulut, Bulent
    Ormeci, Merve Nur
    Atasev, Ozan
    Vidot, Loick
    Cicin, Irfan
    FUTURE ONCOLOGY, 2022, 18 (29) : 3267 - 3276
  • [26] Multi-institutional analysis of real-world activity and safety of trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer
    Arrichiello, G.
    Martinelli, E.
    Troiani, T.
    Incoronato, P.
    Nacca, V.
    Paragliola, F.
    Napolitano, R.
    Suarato, G.
    Nicastro, A.
    Perrone, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S295 - S295
  • [27] Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy for chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis
    de Moraes, Francisco Cezar Aquino
    Pessoa, Felipe Dirceu Dantas Leite
    Ribeiro, Caio Henrique Duarte de Castro
    Fernandes, Marianne Rodrigues
    Burbano, Rommel Mario Rodriguez
    dos Santos, Ney Pereira Carneiro
    BMC CANCER, 2024, 24 (01)
  • [28] Trifluridine/tipiracil plus bevacizumab (FTD/TPI plus BEV) and trifluridine/tipiracil (FTD/TPI) monotherapy in metastatic colorectal cancer (mCRC): Results of a meta-analysis.
    Yoshino, Takayuki
    Taieb, Julien
    Andre, Thierry
    Kuboki, Yasutoshi
    Pfeiffer, Per
    Kumar, Amit
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [30] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
12345